ArticleThe Journal of infectious diseases2024

Monovalent SARS-CoV-2 mRNA Vaccine Does not Boost Omicron-Specific Immune Response in Diabetic and Control Pediatric Patients.

Alan Sariol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.